Dr Saumya Jamuar, discusses his Somatic Mutation and Neurogenetics Research on MiSeq

Date: Friday,6th May 2016

Time: 1:00 pm (AU) | 3:00 pm (NZ) |11:00 am (SG) | 8:30 am (India)

De Saumya
Dr Saum
ya Jamuar,
Consultant, Genetics Service, Department of Paediatrics, KK Women’s and Children’s Hospital, Singapore
Clinical Fellow, Christopher A. Walsh Lab, Harvard Medical School, Boston, USA
Co-founder, Global Gene Corporation Pte Ltd, Singapore
Clincal Lead, Precision Medicine Initiative (PRISM), Singapore
Clinical Lead, Singapore Childhood Undiagnosed Disease Programme, Singapore

Register Now

Dr Saumya Jamuar is a Consultant in the Genetics Service at KKH, co-founder of Global Gene Corp and serves as the Clinical Lead of the Precision Medicine Initiative and Singapore Childhood Undiagnosed Disease Programme. He completed his Genetics Fellowship at the Harvard Medical School Genetics Training Program and worked as a post-doctoral fellow in Christopher A Walsh lab in Harvard Medical School from January 2012- December 2013.

He is actively involved in research and has presented at both local and international meetings. His research areas include thalassaemia, dysmorphology and associated molecular and cytogenetic technology, skeletal dysplasia, and neurodevelopmental genetics. He was awarded the Young Investigator Award at the American Epilepsy Society meeting for his work on targeted resequencing on patients with epileptic encephalopathy. He is also the recipient of the 2015 Singhealth Outstanding Young Researcher Award.


For Research Use Only. Not for use in diagnostic procedures.